Showing results (141-150 of 162) with videos related to
Sort By:
Pageof 17
The Journal of Infectious Diseases|August 22, 2020
Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral TherapyRajesh T Gandhi, Joshua C Cyktor, Ronald J Bosch, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 29, 2024
Persistence of a Skewed Repertoire of NK Cells in People with HIV-1 on Long-Term Antiretroviral TherapyRenee R Anderko, Allison E DePuyt, Rhianna Bronson, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|December 8, 2021
SARS-CoV-2 Infection Among People Living With HIV Compared With People Without HIV: Survey Results From the MACS-WIHS Combined Cohort StudyGypsyamber D'Souza, Weiqun Tong, Deborah Gustafson, et al.Clinical and Vaccine Immunology : CVI|June 24, 2011
Multisite comparison of high-sensitivity multiplex cytokine assaysElizabeth Crabb Breen, Sandra M Reynolds, Christopher Cox, et al.AIDS (London, England)|October 22, 2019
T cells with high PD-1 expression are associated with lower HIV-specific immune responses despite long-term antiretroviral therapyBernard J C Macatangay, Rajesh T Gandhi, Richard B Jones, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 20, 2012
Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin B-cell lymphoma riskShehnaz K Hussain, Weiming Zhu, Shen-Chih Chang, et al.AIDS (London, England)|November 5, 2024
Medical mistrust and vaccine-hesitant attitudes explain SARS-CoV-2 vaccination disparities in a mixed serostatus cohortM Reuel Friedman, Gina Wingood, Kristen D Krause, et al.The Journal of Infectious Diseases|November 30, 2023
SARS-CoV-2 mRNA Vaccines Induce Greater Complement Activation and Decreased Viremia and Nef Antibodies in Men With HIV-1Dylan J Tuttle, Priscila M S Castanha, Amro Nasser, et al.Plos One|April 5, 2013
The impact of HAART on the respiratory complications of HIV infection: longitudinal trends in the MACS and WIHS cohortsMatthew R Gingo, G K Balasubramani, Lawrence Kingsley, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2018
Safety and Immunogenicity of Zoster Vaccine Live in Human Immunodeficiency Virus-Infected Adults With CD4+ Cell Counts >200 Cells/mL Virologically Suppressed on Antiretroviral TherapyConstance A Benson, Janet W Andersen, Bernard J C Macatangay, et al.Pageof 17